Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Horvath currently holds 25,480 shares of Panbela Therapeutics, Inc. (PBLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Horvath has been a net seller of PBLA stock. They have purchased $0 and sold $29.7K worth of shares.
Susan Horvath's most recent insider trade was on Oct 1, 2024, when they sold 25,480 shares at $0.00 per share.
Susan Horvath serves as Executive at Panbela Therapeutics, Inc. (PBLA). They have executed 18 insider transactions totaling $29.7K over their tenure at the company.
Susan Horvath holds the position of Executive at Panbela Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Susan Horvath has shown a selling trading pattern, with $0 in total purchases and $29.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan Horvath was on Dec 19, 2006, when they sold $100.7K worth of CNXS shares. This transaction involved 6,400 shares at $15.74 per share.
Susan Horvath currently owns 25,480 shares of Panbela Therapeutics, Inc. (PBLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Horvath's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Horvath has 18 Form 4 filings on record as an insider at Panbela Therapeutics, Inc..
Set alerts for Susan Horvath and 40,000+ other insiders.